Aβ, a key molecule in the AD pathogenesis, leads to neurotoxicity and neuronal loss (Park et al., 2018), and increases production of Iba-1, TNF-α, and IL-1β levels, known as inflammatory factors, in the brain of patients with AD (Akiyama et al., 2000). Here, IL1B is linked to Alzheimer disease.